Fluidized-Bed Bioreactors Market

Fluidized-bed Bioreactors market Forecast and CAGR

According to the latest research by Fact.MR, fluidized-bed bioreactors market is set to experience xx% growth during the year 2021-2031. With increasing research in finding its applications in healthcare field, the market according to research conducted by FactMR will see a steady growth over the forecast period of 2021-2031.

What is driving the demand for fluidized-bed bioreactors market?

The rising demand for proper treatment of biological waste water generated in healthcare settings in maintaining proper hygiene to protect the health as well as the environment is the major factor boosting the fluidized bed-bioreactors market. Most commonly it is seen that activated sludge process is applied to treating the biological wastewater despite of its lengthier time span. This might be due to its cost-effective nature.

Researchers at University of Western Ontario succeeded in creating a fluidized-bed bioreactor, which according to pilot studies was able to eliminate 90% - organic matter and 80% - nitrogen. This process is also shown to produce 1/3rd less sludge than the original widely used process. This could potential be game changer in wastewater treatment in healthcare settings.

Another interesting factor that plays a crucial role in potential increase in this market is, the application of this bioreactor in bio-artificial liver systems. “Encapsulated hepatocytes (liver cells) can be mass transferred without damaging the cells in the process to the bio-artificial liver systems. This will aid in treatment of liver ailments like hepatic failure." says the study published in PubMed Central, hence is expected to boost the market demand.

Can fluidized-bed bioreactors be used for 3D cell cultures?

According to a 2020 study published in PubMed Central, a scaled-down version of a regular fluidized-bed bioreactor can provide a more controlled and dynamic environment for the creation of various cell cultures. This cell culture can further be used for the construction of 3D cell culture where the tissues are better visible for an all-round analysis of the culture.

In-vivo conditions can be reproduced more scrupulously and in a very cost-effective manner for an extended analysis of the culture. Furthermore, use of animal models in research studies can be reduced. This will promote researchers to further develop products with vast applications in the healthcare setting increasing its demand in the market.

U.S and Canada Fluidized-bed bioreactor market

The healthcare system of the U.S. is well known for its advanced infrastructure and expenditure. Various regulatory rules and insurance policies are adopted to control the care regime of the country. Several cost-effective measures to reduce their burden on healthcare are also adopted by United States.

The presence of major players in bioreactor market such as Parr Instrument Company will certainly prove beneficial for the market as with increasing research in finding out various applications of these bioreactors will certainly impact the market positively.

Europe Fluidized-bed bioreactors market

According to recent reports by Masterinox from February 2021, Italy is looking at the bioreactors as a potentially important role player in production of COVID-19 vaccines. This company has developed a new type of forced-circulation crystallizer which can be used in various process in the pharmaceutical and biopharmaceutical industry.

These kinds of innovative and novel concepts in exploring other applications of bioreactors makes Europe second most prime player in the market. Leading companies in Europe are; Masterinox, Soldo Cavitators.

Who are the key manufacturing supplying companies in Fluidized-bed Bioreactor market?

Key manufacturers and suppliers in the market are

• Procedyne Corp
• Sartorius AG
• Albertus Energy Inc
• Surface Combustion Inc.
• Parr Instrument Company
• Amar Equipments Pvt Ltd
• &P Littleford
• Soldo Cavitators
• Tema Process BV
• Masterinox,

Fluidized-bed Bioreactor market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Key Segment

• By Technology:

  • Diversion-type microcapsule-suspension fluidized bed bioreactor (DMFBB)
  • Circulating Fluidized-bed Bioreactor (CFBBR)
  • Small/laboratory-scale fluidized bed bioreactor (sFBB)
  • Bio-artificial liver systems

• By Application:

  • Biological Wastewater Treatment
  • Treatment of Hepatic Failure
  • 3D Cell Culture

• By End User:

  • Hospitals and clinics
  • Research Institutions
  • Laboratories
  • Medical device manufacturing companies
  • Biopharmaceutical Companies

• By Region:

  • North America
    • Latin America
  • Europe
    • South Asia
  • East Asia
    • Oceania
  • Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.